MX2022016388A - Compuestos de piperidina sustituida y su uso. - Google Patents

Compuestos de piperidina sustituida y su uso.

Info

Publication number
MX2022016388A
MX2022016388A MX2022016388A MX2022016388A MX2022016388A MX 2022016388 A MX2022016388 A MX 2022016388A MX 2022016388 A MX2022016388 A MX 2022016388A MX 2022016388 A MX2022016388 A MX 2022016388A MX 2022016388 A MX2022016388 A MX 2022016388A
Authority
MX
Mexico
Prior art keywords
application
piperidine compound
substituted piperidine
iii
compounds
Prior art date
Application number
MX2022016388A
Other languages
English (en)
Inventor
Keiichi Sorimachi
Takafumi Motoki
Yu Yoshida
Makoto Kotake
Yoichi Kita
Toshiyuki OHFUSA
Taro ASABA
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of MX2022016388A publication Critical patent/MX2022016388A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)

Abstract

Se proporcionan compuestos representados por las siguientes fórmulas (I), (II), (III) y (IV) que tienen actividad activante del receptor de orexina tipo 2, o sus sales farmacéuticamente aceptables. (ver Fórmulas).
MX2022016388A 2020-07-17 2021-07-15 Compuestos de piperidina sustituida y su uso. MX2022016388A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020122864 2020-07-17
PCT/JP2021/026649 WO2022014680A1 (ja) 2020-07-17 2021-07-15 置換ピペリジン化合物及びその用途

Publications (1)

Publication Number Publication Date
MX2022016388A true MX2022016388A (es) 2023-01-30

Family

ID=79291962

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022016388A MX2022016388A (es) 2020-07-17 2021-07-15 Compuestos de piperidina sustituida y su uso.

Country Status (17)

Country Link
US (1) US11479552B2 (es)
EP (1) EP4151277A1 (es)
JP (1) JP7190612B2 (es)
KR (1) KR20230040953A (es)
CN (1) CN115884971A (es)
AR (1) AR122973A1 (es)
AU (1) AU2021308053A1 (es)
BR (1) BR112022026161A2 (es)
CA (1) CA3187835A1 (es)
CL (1) CL2022003666A1 (es)
CO (1) CO2022018446A2 (es)
IL (1) IL299125A (es)
MX (1) MX2022016388A (es)
PE (1) PE20231103A1 (es)
TW (1) TW202216705A (es)
WO (1) WO2022014680A1 (es)
ZA (1) ZA202213562B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112022009938A2 (pt) 2019-11-25 2022-09-13 Alkermes Inc Compostos macrocíclicos substituídos e métodos de tratamento relacionados
US11760747B2 (en) 2020-12-21 2023-09-19 Alkermes, Inc. Substituted piperidino compounds and related methods of treatment
WO2023136279A1 (ja) * 2022-01-14 2023-07-20 エーザイ・アール・アンド・ディー・マネジメント株式会社 置換ピペリジン化合物の結晶並びに置換ピペリジン化合物の塩及びそれらの結晶
WO2024075825A1 (ja) * 2022-10-07 2024-04-11 キッセイ薬品工業株式会社 シクロペンタン化合物
WO2024095158A1 (en) 2022-10-31 2024-05-10 Takeda Pharmaceutical Company Limited Dosing of orexin type 2 receptor agonists

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG34208A1 (en) 1995-03-01 1996-12-06 Guy Andrew Vaz Blast and fragment resistant polyurethane boot sole for safety footwear
WO1996034877A1 (en) 1995-05-05 1996-11-07 Human Genome Sciences, Inc. Human neuropeptide receptor
US6309854B1 (en) 1996-12-17 2001-10-30 Smithkline Beecham Corporation Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
US6159605A (en) 1997-02-18 2000-12-12 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Ink-jet recording sheet
US5935814A (en) 1997-04-30 1999-08-10 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72Y receptor
US6020157A (en) 1997-04-30 2000-02-01 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72X receptor
US6166193A (en) 1997-07-25 2000-12-26 Board Of Regents, University Of Texas System Polynucleotides encoding MY1 receptor
KR100327888B1 (ko) 1999-07-14 2002-03-09 정숭렬 도로포장 파손촉진 시험장치의 무선제어 시스템
CA2551037A1 (en) * 2003-09-22 2005-03-31 Banyu Pharmaceutical Co., Ltd. Novel piperidine derivative
NZ553622A (en) 2004-10-20 2010-08-27 Neurosearch As Novel diazabicyclic aryl derivatives and their medical use
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
TW201444849A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途

Also Published As

Publication number Publication date
CL2022003666A1 (es) 2023-05-26
KR20230040953A (ko) 2023-03-23
ZA202213562B (en) 2023-10-25
CA3187835A1 (en) 2022-01-20
JPWO2022014680A1 (es) 2022-01-20
BR112022026161A2 (pt) 2023-01-31
US20220017517A1 (en) 2022-01-20
US11479552B2 (en) 2022-10-25
IL299125A (en) 2023-02-01
EP4151277A1 (en) 2023-03-22
AU2021308053A1 (en) 2023-02-02
AR122973A1 (es) 2022-10-19
JP7190612B2 (ja) 2022-12-15
TW202216705A (zh) 2022-05-01
PE20231103A1 (es) 2023-07-19
WO2022014680A1 (ja) 2022-01-20
CN115884971A (zh) 2023-03-31
CO2022018446A2 (es) 2023-03-07

Similar Documents

Publication Publication Date Title
MX2022016388A (es) Compuestos de piperidina sustituida y su uso.
MX2022016212A (es) Profármacos de tripamina.
PH12020500236A1 (en) Heterocyclic compund and use thereof
CL2022001731A1 (es) Inhibidores de egfr.
MX2023001517A (es) Inhibidor del factor b del complemento, y composicion farmaceutica del mismo, metodo de preparacion del mismo y uso del mismo.
MX2021008241A (es) Compuesto heterociclico y su uso.
TN2018000262A1 (en) Substituted piperidine compound and use there of.
IS6902A (is) N-setin heterósýklísk NMDA/NR2B mótlyf sem ekki eru arýl
PH12020500673A1 (en) Compounds
SG11201810704WA (en) Sulfonamide compound or salt thereof
TN2011000222A1 (en) Melanocortin receptor agonists
MXPA04010625A (es) Antagonista de receptor de taquicinina.
ZA202201503B (en) Urea compound for antagonizing lpa1 receptor
MY155212A (en) Quaternary ammonium salt compounds
PH12016502358B1 (en) Novel pyrrolidine compound and application as melanocortin receptor agonist
AR058085A1 (es) Sal de dihidrogeno fosfato de un antagonista del receptor de prostaglandina d2. composiciones farmaceuticas.
EA200700365A1 (ru) Производные индол-2-карбоксамидина как антагонисты nmda рецептора
UA109525C2 (xx) Алкіламідна сполука і її застосування
MX2022006783A (es) Nuevos derivados de metilquinazolinona.
MA50093B1 (fr) Composé pentacyclique
MX2022006653A (es) Compuestos para modular la actividad de fxr y usos de los mismos.
NO20080165L (no) Alfa-(aryl-OR heteroaryl-metyl)-beta piperidinopropanamidforbindelser som ORL1-receptorantagonister
ZA202206266B (en) Pd-l1 antagonist compound
PH12021550601A1 (en) Tlr8 agonist
CR20220153A (es) Derivados de 2–azaespiro [3.4] octano como agonistas de m4